This depends on the nature of the study’s clinical interventions. For example, if the study looks at a direct treatment approach that may supplement or replace opioids and there are possible harms associated with those alternative non-opioid treatments, then PCORI would be interested in the harms associated both with those non-opioid interventions as well as the opioid component of the study.
Medical side effects of treatment are listed as a potential key outcome. Does this mean side effects of the comparators being evaluated or does it mean side effects of opioid therapy?
Have more questions? Submit a request